STS-001: An explorative clinical study to assess the potential of intravenously administered sodium thiosulfate in subjects with primary Raynaud’s phenomenon
Raynaud’s phenomenon causes the small blood vessels in your fingers and toes to narrow when you are cold or stressed, often turning them white or blue and causing pain or numbness. This early-stage study tests a medicine called sodium thiosulfate (given via a drip into a vein) to see if it can improve blood circulation in the hands. During the trial, doctors will cool your hand and use gentle heat sensors and light monitors to measure how quickly your fingers warm up again. They will also take blood tests and check your heart and blood pressure to make sure the treatment is safe and well tolerated. The study is open to adults aged 18 and over with primary Raynaud's who want to help researchers find potential new treatments for this uncomfortable condition.
Auf einen Blick
Worum geht es in dieser Studie?
Raynaud’s phenomenon is a common and often uncomfortable condition where the tiny blood vessels in your extremities—most often your fingers and toes—narrow suddenly in response to cold weather or emotional stress. This reduces blood supply, causing the skin to change colour from white to blue and then red, frequently accompanied by throbbing, numbness, or pain. While many people manage by wearing warm gloves, some people experience severe symptoms that disrupt their daily lives, and better treatments are needed.
In this study, researchers are exploring whether a medication called sodium thiosulfate can help relax these blood vessels and protect them from sudden narrowing. Sodium thiosulfate works in part by reducing stress and irritation inside blood vessels. Researchers hope that giving this medicine directly into the bloodstream will help blood flow more freely through the hands and reduce the time it takes for fingers to recover after getting cold.
This is an early exploratory trial (Phase II), which means it focuses both on whether the treatment works and how safe it is. By measuring how your hands respond to temperature changes and tracking how your body processes the medicine, doctors hope to gather key evidence that could lead to new therapies for Raynaud’s in the future.
Wichtige Erkenntnisse
- Tests whether an intravenous medicine (sodium thiosulfate) can improve blood flow in Raynaud’s.
- Open to adults aged 18 and older diagnosed with primary Raynaud’s phenomenon.
- Involves receiving the medicine through a drip and having pain-free hand temperature scans.
- Includes thorough health checks such as heart traces (ECGs) and blood pressure monitoring.
- Participation is entirely voluntary, and you can stop at any time.
Wer könnte berechtigt sein?
This study is looking for adults aged 18 and older who have been diagnosed with primary Raynaud’s phenomenon. Primary Raynaud’s means your symptoms happen on their own, rather than being caused by another underlying health condition like lupus or scleroderma.
Both men and women can join. Because the trial involves testing blood flow and receiving medication through a drip, you will need to have veins that can safely take a needle and be well enough to complete simple cooling tests on your hands.
The trial team will check your full medical history and any medications you are taking before you join to make sure it is completely safe for you to take part.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- I am at least 18 years old.
- I have been told by a doctor that I have primary Raynaud’s phenomenon.
- My Raynaud’s is not caused by another condition like scleroderma or lupus.
- I am comfortable receiving medicine through a drip in my arm.
- I am willing to attend clinic appointments for tests and monitoring.
Was beinhaltet die Teilnahme?
If you take part, you will attend a clinic where the trial team will give you the study medicine, sodium thiosulfate, through a small tube placed into a vein in your arm (an intravenous drip). The team will test different dose strengths to see how your body reacts.
To see if the medicine improves blood flow, doctors will place one of your hands in cool water or cold air and monitor it using special cameras and light sensors. These pain-free tools measure blood circulation and track how fast your fingers warm back up. You will also have routine safety checks, including continuous blood pressure monitoring, heart traces (ECGs), and blood tests to see how quickly the medicine leaves your system.
The trial team will explain the exact number of visits and hours required before you agree to take part, and they will support you closely throughout each stage.
Potenzielle Risiken und Vorteile
Standorte (1)
- —UnbestätigtNiederlande
Häufige Fragen
What is sodium thiosulfate?
It is a liquid medicine given through a drip that researchers believe may help calm irritation in blood vessels and improve blood flow.
Are the cold tests painful?
The cooling test may feel chilly or briefly uncomfortable—similar to holding a cold drink—but it is designed to be gentle and safe.
Will taking part cure my Raynaud’s?
No, this is an early study to see if the medicine works and is safe. It is not guaranteed to cure your symptoms.
Do I have to pay to take part?
No, clinical trials in the UK are free to join, and travel expenses are often reimbursed by the study team.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes, you have the right to withdraw from the trial at any time, for any reason, without your regular care being affected.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.